Home Digestive Disorders IBD: Ulcerative Colitis What’s Health Canada Saying about Biosimilars?

IBD: Ulcerative Colitis

What’s Health Canada Saying about Biosimilars?

Tags: ,

A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!

This video was made possible by an unrestricted educational grant by Pfizer Canada. 

Related Articles

Uncovering Biologics: Your IBD BodyGuard!
Uncovering Biologics: Your IBD BodyGuard!

Tags:

Read More

Infusion Clinics and COVID-19 Safety Protocols

Tags: ,

It’s all over the news, there’s a global pandemic going on and the number one message is to STAY INSIDE! Especially if you’re one of the […]

Read More

Robbies Rainbow You Me and IBD Magazine
Robbie’s Rainbow “You, Me and IBD” Magazine

Tags:

CDHF is SO excited to share Robbie’s Rainbow’s latest edition of “You, Me and IBD” – an educational IBD magazine for children, teens, and parents, in […]

Read More

What’s Health Canada Saying about Biosimilars?

https://www.youtube.com/watch?v=1OeDtXWn3_8
A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!